Michael Scolaro

Michael Scolaro

Nov 19, 2017

Group 6 Copy 161
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Viral Causes of Lung Cancer

We have special access to blood specimens collected from more than 9,000 cancer free people. These individuals...

Can We Defeat EBOLA with an Experimental CANCER Drug?

The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and...

Can cockroaches help us cure tularemia?

Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also a...

Backer Badge Funded